Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences held its 40th AGM on September 23, 2025, where all six resolutions were passed. The resolutions included adopting FY2024-25 audited financials, re-appointing director Mr. Dineshkumar Rathod (DIN: 09406871), re-appointing the statutory auditor, appointing Mr. Kelash Bunkar (DIN: 10911360) as Independent Director, and two special resolutions to enhance borrowing limits (Section 180(1)(c)) and raise investment/loan/guarantee powers (Section 186). Out of 36,156 shareholders on record, only 36 public shareholders attended in person; no promoter group members were present or voted. Of the 66,069,000 public non-institutional shares, only 15.4% (about 1.02 crore shares) were voted, with roughly 100% in favour and just 2 votes against each resolution. Scrutinizer Daksha Negi confirmed the e-voting and poll process was conducted fairly via NSDL.
Routine procedural clearance for shareholders — all resolutions passed overwhelmingly with near-unanimous support. Shareholders should note the two special resolutions that expand the company's borrowing capacity and authority to make investments, give loans, and provide guarantees, which could increase the company's financial leverage and related-party transaction flexibility going forward.